Date |
Company |
Amount |
Funding type |
Investors |
Therapeutic area |
Type of Information |
2013-04-24 |
Genticel (France) |
€ 18.2 million |
fundraising |
Wellington Partners (USA) IDInvest Partners (France) Edmond de Rothschild Investment Partners (EdRIP) (France) InnoBio fund (France) Amundi Private Equity Funds (France) |
Infectious diseases - Gynecology - Women's health |
Fundraising |
2013-04-24 |
Galapagos (Belgium) |
€ 54 million |
private placement |
institutional investors in Europe and USA |
Autoimmune diseases – Inflammatory diseases - Rheumatic diseases |
Private placement |
2013-04-22 |
Curetis (Germany) |
€ 20 million |
series B financing round |
HBM Partners (Cayman Islands) aeris Capital (Switzerland) LSP Life Sciences Partners (The Netherlands) Forbion Capital (The Netherlands) BioMedInvest (Switzerland) Roche Venture Fund (Switzerland) CD Venture (Germany) KfW (Germany) Curetis’ management , several of the company\'s founders, private investors, board members |
Infectious diseases |
Fundraising |
2013-04-18 |
Allecra Therapeutics (Germany - France) |
€15 million |
Series A financing round |
Forbion Capital Partners (The Netherlands) Edmond de Rothschild Investment Partners (France) EMBL Ventures (Germany) |
Infectious diseases |
Fundraising |
2013-04-18 |
Actogenix (Belgium) |
€ 10.7 million |
series B financing round |
Saffelberg Investments (Belgium) Gimv (Belgium) Biotech Fund Flanders (Belgium) Baekeland Fund (Belgium) BioVest (Belgium) LSP Life Science Partners (The Netherlands) Aescap Venture (The Netherlands) Ventech (France) |
|
Fundraising |
2013-04-17 |
Rodos BioTarget (Germany) |
€ 2.6 million |
|
InvestImpuls-Fonds of the region of Hannover |
Cancer - Oncology - Infectious diseases |
Fundraising |
2013-04-16 |
Auris Medical (Switzerland) |
CHF 47.1 million (€38.7 million) |
Series C financing round |
Sofinnova Ventures (USA) Sofinnova Partners (France) |
Otorhinolaryngology |
Fundraising |
2013-04-15 |
Avilex Pharma (Denmark) |
undisclosed |
seed funding |
Novo Seeds (Denmark) |
CNS diseases - Neurological diseases |
Fundraising |
2013-04-12 |
Neuronax (France) |
150 k€ |
crowdfunding |
WiSEED investors community |
CNS diseases |
Fundraising |
2013-04-12 |
Genfit (France) |
€ 14.325 million |
private placement |
|
Cardiovascular diseases - Metabolic diseases - Liver diseases |
Private placement |
2013-04-10 |
BerGenBio (Norway) |
NOK 13 million (€1.5 million) |
grant |
|
Cancer - Oncology |
Grant |
2013-04-09 |
MedDay (France) |
€ 8 miillion |
|
InnoBio (France) Sofinnova Partners (France) |
Neurodegenerative diseases - Metabolic diseases |
Fundraising |
2013-04-09 |
Theradiag (France) |
€1.2 million |
grant |
OSEO (France) |
Diagnostic - Infectious diseases |
Grant |
2013-04-08 |
Canbex Therapeutics (UK) |
£2.1 million (€2.45 million) |
financing round |
Merck Serono Ventures (Germany) UCL Business (UK) the Wellcome Trust (UK) |
Neurodegenerative diseases |
Fundraising |
2013-04-08 |
GenSight Biologics (France) |
€ 32 million |
series A financing round |
Abingworth (UK) - Index Ventures (USA-Switzerland) - Versant Ventures (Switzerland) - Novartis Venture Fund (Switzerland) |
Ophtalmological diseases |
Fundraising |
2013-03-19 |
Addex Therapeutics (Switzerland) |
$ 1 million (€ 0.77 million) |
grant |
The Michael J. Fox Foundation - MJFF (USA) |
Neurodegenerative diseases |
Grant |
2013-03-19 |
Hybrigenics (France) |
€ 0.6 million |
grant |
|
Neurodegenerative diseases |
Grant |
2013-03-11 |
Progenitor Labs (UK) |
£4 million (€2.7 million) |
seed financing |
SR One (UK) |
Regenerative medicine |
Establishment of a new subsidiary in the EU |
2013-03-11 |
Oncodesign (France) |
€ 13.4 million |
grant |
Investing for the Future program (France) |
Cancer - Oncology |
Grant |
2013-03-11 |
Reneuron (UK) |
£1.2 million |
grant |
Biomedical Catalyst Fund (UK) |
Rare diseases - Ophtalmological diseases |
Grant |